US Patent 10081625 5-methyl-1,2,4-oxadiazol-3-yl compounds
Patent 10081625 was granted and assigned to Eli Lilly and Company on September, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10081625 5-methyl-1,2,4-oxadiazol-3-yl compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
